HArmonyCa with Lidocaine combines hyaluronic acid with calcium hydroxyapatite technology to support immediate volume enhancement alongside progressive collagen stimulation. Developed for professional aesthetic use, the product is designed to improve facial structure, contour definition, and skin support in patients presenting with moderate age-related volume depletion.
The hybrid composition differentiates HArmonyCa filler from conventional HA-only fillers by integrating a biostimulatory component intended to support longer-lasting tissue quality improvements. The inclusion of lidocaine may help improve patient comfort during treatment procedures.
HArmonyCa lidocaine 2×1 25ml is widely used in aesthetic clinics for mid-to-lower face rejuvenation and structural enhancement. Product selection, injection technique, and treatment planning should always be determined by trained medical professionals according to individual patient anatomy and treatment goals.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesHArmonyCa with Lidocaine (2 x 1.25ml) is a hybrid injectable dermal filler designed to provide both immediate soft-tissue volumisation and longer-term collagen stimulation. The device combines cross-linked hyaluronic acid (HA) with calcium hydroxyapatite (CaHA) microspheres suspended in a gel carrier. This dual-action formulation aims to support immediate contour correction while stimulating neocollagenesis over time.
The product is intended for use in facial aesthetic procedures involving structural support, lifting, and correction of volume loss in areas affected by age-related tissue changes. Lidocaine is incorporated into the formulation to improve injection comfort during administration.
HArmonyCa filler is commonly positioned within the category of collagen-stimulating hybrid fillers and may be considered in treatment plans targeting facial rejuvenation and contour enhancement. The product is supplied in prefilled syringes for professional administration by qualified medical practitioners under aseptic conditions.
HArmonyCa with Lidocaine belongs to the category of hybrid biostimulatory fillers that combine volumising and collagen-stimulating properties. It is often clinically compared to products such as Radiesse and Profhilo due to its collagen-supporting mechanism.
Like Radiesse, HArmonyCa contains calcium hydroxyapatite microspheres intended to stimulate collagen production. However, HArmonyCa additionally incorporates cross-linked hyaluronic acid, providing immediate hydration and volumising effects associated with HA fillers.
Compared with Profhilo, which primarily focuses on skin bio-remodelling through stabilised hyaluronic acid complexes, HArmonyCa is generally positioned as a structural volumising product with lifting and contouring indications.
The longevity profile of HArmonyCa may also differ from traditional HA fillers because of its combined biostimulatory activity, although duration can vary depending on patient factors, injection technique, and treatment area.
This comparison is provided for clinical orientation only and does not imply interchangeability.
According to publicly available manufacturer information and distributor documentation, HArmonyCa with Lidocaine may be used for:
Specific treatment areas should always be confirmed through the official manufacturer IFU.
The product is intended for administration only by qualified medical professionals trained in aesthetic injectable procedures under aseptic conditions.
Injection depth:
Deep dermal and/or subdermal placement depending on treatment indication.
Volume per injection point:
Not provided by manufacturer in publicly accessible documentation.
Recommended needle/cannula gauge:
Not provided by manufacturer in publicly accessible documentation.
Frequency / number of sessions:
Not provided by manufacturer in publicly accessible documentation.
Professional-use statement:
HArmonyCa with Lidocaine should be administered only by appropriately trained healthcare professionals familiar with facial anatomy, injection techniques, and complication management.
Some practitioners apply advanced vectoring or layering techniques with harmonyca filler; however, these methods are not included in the manufacturer’s official IFU guidance.
HA concentration: not provided by manufacturer.
Lidocaine concentration: not provided by manufacturer.
HArmonyCa with Lidocaine is supplied as:
The product is intended for single-patient professional use and supplied in sterile packaging.
Longevity / duration:
Clinical duration varies according to patient metabolism, injection depth, anatomical region, and practitioner technique. Public manufacturer materials indicate prolonged aesthetic effects associated with collagen stimulation; however, a precise duration range is not consistently specified in publicly available IFU documentation.
Shelf life:
Not provided by manufacturer in publicly accessible documentation.
Healthcare professionals researching harmonyca filler price or harmonyca lidocaine price should verify storage conditions, expiry dating, and distributor compliance through authorised supply channels.
HArmonyCa with Lidocaine should not be used in patients with:
As with all injectable fillers, potential adverse events may include swelling, bruising, erythema, tenderness, nodules, vascular compromise, or delayed inflammatory reactions.
The device should only be administered by practitioners trained in facial anatomy and complication management protocols.
If additional regional registrations are required, practitioners should verify status through MHRA, EUDAMED, or local regulatory authorities.
HArmonyCa with Lidocaine is used for facial volumisation, contour support, and collagen-stimulating aesthetic treatments. The product combines hyaluronic acid with calcium hydroxyapatite microspheres to provide immediate volume correction alongside longer-term tissue support. It is commonly used in the cheeks, jawline, and lower face where structural definition and age-related volume loss are concerns. Treatment suitability depends on patient anatomy and clinical assessment by a qualified practitioner.
Traditional hyaluronic acid fillers primarily provide hydration and soft-tissue volume replacement. HArmonyCa filler additionally contains calcium hydroxyapatite microspheres, which are associated with collagen stimulation and tissue remodelling. This hybrid mechanism may contribute to longer-lasting structural support compared with some HA-only products. However, treatment outcomes vary depending on injection technique, patient characteristics, and treatment area.
Yes. HArmonyCa with Lidocaine contains lidocaine hydrochloride to support patient comfort during injection procedures. Lidocaine is a local anaesthetic commonly incorporated into injectable fillers to reduce discomfort during administration. The precise lidocaine concentration was not clearly specified in the publicly accessible manufacturer information reviewed for this description.
The duration of aesthetic effect varies according to metabolism, injection area, lifestyle factors, and practitioner technique. Manufacturer and distributor materials describe HArmonyCa as a collagen-stimulating hybrid filler designed for prolonged tissue support; however, a definitive duration range was not consistently specified in publicly available IFU documents. Practitioners should discuss expected maintenance schedules individually with patients.
HArmonyCa shares similarities with biostimulatory fillers such as Radiesse because both involve calcium hydroxyapatite technology associated with collagen stimulation. However, HArmonyCa also incorporates cross-linked hyaluronic acid, giving it immediate volumising characteristics associated with HA fillers. This dual composition positions the product between traditional HA fillers and purely biostimulatory injectables. Product selection depends on treatment goals, facial anatomy, and practitioner preference.
Let’s talk on WhatsApp